T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.
Am J Hematol
; 99(3): 494-496, 2024 03.
Article
en En
| MEDLINE
| ID: mdl-38240336
ABSTRACT
Survival remains poor for T-cell prolymphocytic leukemia, though treatment in recent years, associated with access to novel therapies, and management at academic medical centers is associated with improved outcomes. There remains a critical need to improve the available treatment options for this population, and access to specialized academic medical centers, comprehensive supportive care, clinical trials, and early palliative care remains essential for T-PLL patients.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Leucemia Prolinfocítica de Células T
/
Trasplante de Células Madre Hematopoyéticas
Tipo de estudio:
Screening_studies
Límite:
Humans
Idioma:
En
Revista:
Am J Hematol
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA